Oak Street Health, Inc.
OSH · NYSE
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.71 | -0.99 | 0.34 | -0.06 |
| FCF Yield | -1.19% | -2.46% | -1.09% | -2.90% |
| EV / EBITDA | 121.54 | -48.63 | -55.70 | -34.76 |
| Quality | ||||
| ROIC | -3.88% | -12.12% | -10.90% | -9.67% |
| Gross Margin | 100.00% | 0.16% | 0.86% | 6.34% |
| Cash Conversion Ratio | 2.10 | 0.72 | 0.26 | 0.59 |
| Growth | ||||
| Revenue 3-Year CAGR | 34.88% | 34.77% | 34.78% | 35.67% |
| Free Cash Flow Growth | 6.80% | -90.45% | 42.83% | 2.61% |
| Safety | ||||
| Net Debt / EBITDA | 14.20 | -9.68 | -9.13 | -8.04 |
| Interest Coverage | 72.33 | -94.50 | 0.00 | -225.40 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.36 | -2.28 | -3.96 | -3.88 |